PROS1 and COVID-19: For example, convalescent COVID-19 patients produce antibodies against various SARS-CoV-2 structural proteins, such as surface-expressed membrane (M) protein [95,96,97], which may contribute to the neutralizing capacity of convalescent sera, as has been shown for SARS-CoV-1 M-specific antibodies [98].